GENEVA, July 6 -- NANJING LEGEND BIOTECH CO., LTD. filed a patent application (CN2025/145175) for “METHODS OF REDUCING ALLOGENIC REJECTION OF CELL THERAPY”. With publication no. WO/2026/138886, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61P 37/06
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....